Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Target Advancement Program, 2018
    Evaluation of PARIS ASOs in Models of Parkinson's Disease

    Study Rationale:
    The parkin-interacting substrate (PARIS) prevents genes that are important in the survival of dopamine neurons from working by limiting their expression in neurons. Previously we...

  • Therapeutic Pipeline Program, 2018
    Bitopertin to Alleviate Dyskinesia in Parkinson's Disease

    Study Rationale:
    Levodopa-induced dyskinesia is abnormal involuntary movements that can affect people with Parkinson's disease after years of treatment. Available therapies for dyskinesia are only...

  • Research Grant, 2018
    pS65-Ub as a Biomarker for Parkinson's Disease

    Study Rationale:
    The PINK1 and parkin proteins jointly ensure quality control of mitochondria, the cell's powerhouse. Together they modify damaged mitochondria with phosphorylated ubiquitin (pS65-Ub)...

  • Research Grant, 2018
    Exploring the Effect of Altitude on Parkinson's Disease

    Study Rationale:
    There is a lot of anecdotal evidence that the symptoms of Parkinson's disease (PD) may improve markedly during visits to high-altitude destinations. Given the significant, but as yet...

  • Research Grant, 2018
    URMC-099 in an In Vivo AAV-hSYN Model of Parkinson’s Disease

    Study Rationale:
    Parkinson's disease (PD) can be modeled by over-expressing human synuclein, a protein that can clump together to disrupt normal signaling in dopamine-containing neurons, which in turn...

  • Research Grant, 2018
    LRRK2-Mediated Rab Protein Phosphorylation in Monocytes and Neutrophils in Parkinson's Disease

    Study Rationale:
    Mutations in the LRRK2 gene cause some forms of Parkinson's disease. Studying this gene's effects has provided insight into the physiological processes that lead to genetic and...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.